Why is a patient's response the final test of a drug's bioavailability?

A patient's response is considered the final test of a drug's bioavailability because individual physiological factors create significant variability in how drugs are absorbed, distributed, and acted upon within the body.12

While bioavailability measures the rate and extent to which a drug reaches its site of physiological activity, the actual clinical effect depends on a complex interplay of variables unique to each person, including:

• Biological Factors: Age, genetics, nutrition, and existing disease states significantly alter how a body metabolizes and excretes medication.12
• Pharmacokinetics: Differences in organ function, such as kidney or liver efficiency, mean that the same dose can result in vastly different concentrations at the site of action.1
• Individual Sensitivity: Because individuals possess different thresholds for drug effects, a dose that is therapeutic for one person may be ineffective or toxic for another.12

Ultimately, because laboratory measurements cannot fully replicate the internal environment of a specific patient, the observed clinical response remains the most accurate indicator of whether the drug has successfully achieved its intended therapeutic effect.31